Published In
Archives of Rheumatology
Volume 32 · Issue 1
Pages: 067-070
History
Published Online: March 31, 2017
This work is licensed under a Creative Commons Attribution 4.0 International License.
Gönen MENGİ
Department of Rheumatology, Muğla Sıtkı Koçman University, Education And Research Hospital, Muğla, Turkey
Feride GÖĞÜŞ
Department of Physical Medicine and Rehabilitation, Medical Faculty of Gazi University, Ankara, Turkey
Gönen MENGİ, & Feride GÖĞÜŞ. (2017). A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology, 32(1), 067–070. https://doi.org/10.5606/ArchRheumatol.2017.6055
Abstract
Anti-tumor necrosis factor alpha (anti-TNF-a) therapy has been widely used for the management of rheumatologic diseases. The most frequent adverse effects of anti-TNF-a therapy are infections and malignancies while sarcoidosis is a rare condition. On the other hand, anti-TNF-a therapy has been used in the treatment of sarcoidosis. Elucidation of this paradoxical issue is unclear. In this article, we report an ankylosing spondylitis patient who was diagnosed as sarcoidosis during the period of etanercept usage. Sarcoidosis as a possible adverse effect should be kept in mind during anti-TNF-a therapy.
Similar Articles
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Volume 32 · Issue 1
Pages
067-070
History
Published Online
March 31, 2017
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
Gönen MENGİ
Department of Rheumatology, Muğla Sıtkı Koçman University, Education And Research Hospital, Muğla, Turkey
Feride GÖĞÜŞ
Department of Physical Medicine and Rehabilitation, Medical Faculty of Gazi University, Ankara, Turkey
Cite this Article
Gönen MENGİ, & Feride GÖĞÜŞ. (2017). A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology, 32(1), 067–070. https://doi.org/10.5606/ArchRheumatol.2017.6055
Outlines